ArticleTransplantation and cellular therapy2022

Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy.

Aasha I Hoogland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.